SCHEMBL15418063

SCHEMBL15418063

[CH2]CCn1nc(C(C)N(C(=O)[C@H]2CNCCO2)C2CC2)c2ccccc21

nearest known ligand 0.81

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ REN P00797 20/20 0.81

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15599710 0.91 REN (0.82) REN
SCHEMBL16471501 0.89 REN (1.00) REN
SCHEMBL16471502 0.89 REN (1.00) REN
SCHEMBL16471499 0.89 REN (1.00) REN
SCHEMBL15435684 0.89 REN (1.00) REN
SCHEMBL12526888 0.88 REN (1.00) REN
SCHEMBL17012920 0.88 REN (0.78) REN
SCHEMBL15417995 0.88 REN (0.78) REN
SCHEMBL12526887 0.88 REN (1.00) REN
SCHEMBL12523965 0.87 REN (0.83) REN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2687518-B1 NITROGEN-CONTAINING SATURATED HETEROCYCLIC COMPOUND MITSUBISHI TANABE PHARMA CORP (JP) 2017-11-01 — — EP disclosed
EP-2687518-A1 NITROGEN-CONTAINING SATURATED HETEROCYCLIC COMPOUND Mitsubishi Tanabe Pharma Corporation (JP) 2014-01-22 — — EP disclosed
Send feedback